PLANTAGINIS MAJORIS FOLIUM

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT PLANTAIN LEAF (PLANTAGINIS MAJORIS FOLIA)

Composition:

Active ingredient: plantain leaf (Plantaginis majoris folia);

1 pack contains 50 g of plantain leaf (Plantaginis majoris folia);

1 filter bag contains 1.5 g of plantain leaf (Plantaginis majoris folia).

Pharmaceutical form. Leaves.

Main physicochemical properties: fragments of leaves of various shapes, green to brownish-green in color.

Pharmacotherapeutic group. Expectorants. ATC code R05C A.

Pharmacological properties.

Pharmacodynamics.

The biologically active substances of the drug exert expectorant, anti-inflammatory, analgesic, hemostatic, wound-healing, and bacteriostatic effects; enhance functional activity of the respiratory epithelium, promote secretion and evacuation of mucus from the airways, reduce coughing; stimulate gastric juice secretion and increase acidity; promote cleansing of wound and ulcerated surfaces from pus-forming bacteria and enhance granulation processes in affected tissues.

Clinical characteristics.

Indications.

Respiratory tract diseases (bronchitis, pertussis, pneumosclerosis, pulmonary tuberculosis), gastrointestinal disorders (gastritis and gastric ulcer with reduced acidity, enteritis and enterocolitis) – as part of complex therapy. Externally used as a wound-healing agent.

Contraindications.

Hypersensitivity to the biologically active substances of the drug. Hyperacid gastritis, duodenal ulcer and gastric ulcer with increased acidity; increased blood coagulation and predisposition to thrombosis, reflux esophagitis.

Interaction with other medicinal products and other forms of interaction.

Do not use simultaneously with antitussive drugs and medicinal products that reduce sputum secretion.

Special precautions for use.

Use during pregnancy or breastfeeding.

Upon prescription by a physician in cases where the benefit to the mother outweighs the potential risk to the fetus/child.

Ability to affect reaction speed when driving or operating machinery.

Has no effect.

Method of Administration and Dosage

Place 2 tablespoons of leaves into an enameled container, pour 200 ml of hot boiled water, cover with a lid, and steep in a boiling water bath for 15 minutes. Cool at room temperature for 45 minutes, strain, squeeze the residue into the strained infusion, and adjust the volume of the infusion to 200 ml with boiled water.
Adults should take 1/3 cup of the warm infusion three times daily, 10–15 minutes before meals.
Children:

• 1–3 years: 1 teaspoon
• 2–5 years: 1 dessert spoon
• 5–10 years: 1 tablespoon
• 10–14 years: 1/4 cup
  three times daily, 10–15 minutes before meals.

Place 3 filter packets into a glass or enameled container, pour 200 ml of boiling water, cover and steep for 15 minutes.
Adults should take 1/2 cup of the warm infusion four times daily, 10–15 minutes before meals.
Children:

• 1–3 years: 1 dessert spoon
• 3–5 years: 2 dessert spoons
• 5–10 years: 2 tablespoons
• 10–14 years: 1/3–1/2 cup
  three times daily, 10–15 minutes before meals.

Store the prepared infusion at 8–15°C for no more than 2 days.

Externally: soak a gauze pad with the infusion and apply to affected areas of the skin.

The duration of treatment is determined individually by the physician.

Children

The drug may be used in children aged 1 year and older.

Overdose

No reports available.

Side effects.

Allergic reactions (including hyperemia, rash, itching, skin swelling), heartburn.

Shelf life. 3 years. Do not use after the expiry date stated on the packaging.

Storage conditions. Store in the original packaging at a temperature not exceeding 30 °C, in a place inaccessible to children.

Packaging. 50 g in packs with an inner pouch; 1.5 g in tea bags, 20 pcs in a pack, or in a pack with an inner pouch.

Availability. Over-the-counter.

Manufacturer: JSC "Lektravy".

Manufacturer's address / Location of the applicant and/or the applicant's representative.

21, Kyivske Shose, Zhytomyr, Zhytomyr Oblast, 10001, Ukraine.